loadpatents
name:-0.046610116958618
name:-0.040786981582642
name:-0.0073509216308594
Stauffer; Shaun R. Patent Filings

Stauffer; Shaun R.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Stauffer; Shaun R..The latest application filed is for "wdr5-myc inhibitors".

Company Profile
7.45.46
  • Stauffer; Shaun R. - Brentwood TN
  • STAUFFER; Shaun R. - Cleveland OH
  • Stauffer; Shaun R. - Nashville TN
  • Stauffer; Shaun R. - Schwenksville PA US
  • Stauffer; Shaun R. - Schwenskville PA
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Wdr5-myc Inhibitors
App 20220289673 - Tansey; William P. ;   et al.
2022-09-15
Allosteric Activators Of The Alpha1a-adrenergic Receptor
App 20220227717 - PEREZ; Dianne M. ;   et al.
2022-07-21
WDR5 inhibitors and modulators
Grant 10,844,044 - Alvarado , et al. November 24, 2
2020-11-24
WDR5-MLL1 inhibitors and modulators
Grant 10,807,959 - Gogliotti , et al. October 20, 2
2020-10-20
Wdr5 Inhibitors And Modulators
App 20200102288 - Alvarado; Joseph R. ;   et al.
2020-04-02
Wdr5-mll1 Inhibitors And Modulators
App 20200055824 - Gogliotti; Rocco D. ;   et al.
2020-02-20
WDR5 inhibitors and modulators
Grant 10,501,466 - Fesik , et al. Dec
2019-12-10
Substituted And Fused 6-membered Protease Activated Receptor 4 (par-4) Antagonists
App 20190119300 - Hamm; Heidi E. ;   et al.
2019-04-25
Wdr5 Inhibitors And Modulators
App 20190084988 - Fesik; Stephen W. ;   et al.
2019-03-21
WDR5 inhibitors and modulators
Grant 10,160,763 - Fesik , et al. Dec
2018-12-25
Substituted 5-membered heterocyclic analogs as protease activated receptor 4 (PAR-4) antagonists
Grant 9,963,466 - Hamm , et al. May 8, 2
2018-05-08
Wdr5 Inhibitors And Modulators
App 20180086767 - Fesik; Stephen W. ;   et al.
2018-03-29
Substituted 5-Membered Heterocyclic Analogs as Protease Activated Receptor 4 (PAR-4) Antagonists
App 20170253617 - Hamm; Heidi E. ;   et al.
2017-09-07
Substituted 4-benzyl-3,4-dihydro-2H-benzo[B][1,4]oxazine-2-carboxamide analogs as positive allosteric modulators of muscarinic acetycholine receptor M1
Grant 9,708,278 - Lindsley , et al. July 18, 2
2017-07-18
Substituted indoles as selective protease activated receptor 4 (PAR-4) antagonists
Grant 9,572,794 - Hamm , et al. February 21, 2
2017-02-21
Substituted 4-benzyl-3,4-dihydro-2h-benzo[b][1,4]oxazine-2carboxamide Analogs As Positive Allosteric Modulators Of Muscarinic Acetycholine Receptor M1
App 20170022173 - Lindsley; Craig W. ;   et al.
2017-01-26
Substituted quinazolin-4(3H)-ones, pyrido[3,4-d]pyrimidin-4(3H)-ones, pyrido[3,2-d]pyrimidin-4(3H)-ones and pyrido[2,3-d]pyrimidin-4(3H)-ones as positive allosteric modulators of muscarinic acetycholine receptor M1
Grant 9,540,371 - Lindsley , et al. January 10, 2
2017-01-10
Substituted 1-benzylquinoxalin-2(1H)-one analogs as positive allosteric modulators of muscarinic acetylcholine receptor M1
Grant 9,527,834 - Lindsley , et al. December 27, 2
2016-12-27
Substituted 3-benzylquinoxalin-4(3h)-one Analogs As Positive Allosteric Modulators Of Muscarinic Acetycholine Receptor M1
App 20160102090 - Lindsley; Craig W. ;   et al.
2016-04-14
Substituted Indoles as Selective Protease Activated Receptor 4 (PAR-4) Antagonists
App 20160083363 - Hamm; Heidi E. ;   et al.
2016-03-24
Substituted 1-benzylquinoxalin-2(1h) Analogs As Positive Allosteric Modulators Of Muscarinic Acetylcholine Receptor M1
App 20160075690 - Lindsley; Craig W. ;   et al.
2016-03-17
Substituted pyrazolo[1,5-a]pyrazines as mGluR5 receptor modulators
Grant 9,255,103 - Conn , et al. February 9, 2
2016-02-09
P2X3 receptor antagonists for treatment of pain
Grant 9,238,647 - Burgey , et al. January 19, 2
2016-01-19
Menin-MLL inhibitors and methods of use thereof
Grant 9,212,180 - Grembecka , et al. December 15, 2
2015-12-15
Substituted Bicyclic Alkoxy Pyrazole Analogs As Allosteric Modulators Of Mglur5 Receptors
App 20150216863 - Conn; P. Jeffrey ;   et al.
2015-08-06
Bicyclic oxazole and thiazole compounds and their use as allosteric modulators of mGluR5 receptors
Grant 9,090,632 - Conn , et al. July 28, 2
2015-07-28
Substituted bicyclic alkoxy pyrazole analogs as allosteric modulators of mGluR5 receptors
Grant 9,029,366 - Conn , et al. May 12, 2
2015-05-12
Substituted 6-methylnicotinamides as mGluR5 positive allosteric modulators
Grant 8,969,389 - Conn , et al. March 3, 2
2015-03-03
Menin-mll Inhibitors And Methods Of Use Thereof
App 20140371239 - Grembecka; Jolanta ;   et al.
2014-12-18
Substituted bicyclic alkoxy pyrazole analogs as allosteric modulators of mGluR5 receptors
Grant 8,901,125 - Conn , et al. December 2, 2
2014-12-02
Substituted Imidazopyrimidin-5(6h)-ones As Allosteric Modulators Of Mglur5 Receptors
App 20140329838 - Conn; P. Jeffrey ;   et al.
2014-11-06
Substituted imidazopyrimidin-5(6H)-ones as allosteric modulators of MGLUR5 receptors
Grant 8,865,725 - Conn , et al. October 21, 2
2014-10-21
Naphthyridinone analogs as mGluR5 positive allosteric modulators
Grant 8,853,237 - Conn , et al. October 7, 2
2014-10-07
Bicyclic Pyrazole Compounds As Allosteric Modulators Of Mglur5 Receptors
App 20140213593 - Conn; P. Jeffrey ;   et al.
2014-07-31
Dihydronaphthyridinyl(organo)methanone analogs as positive allosteric mGluR5 modulators
Grant 8,710,074 - Conn , et al. April 29, 2
2014-04-29
Substituted pyrazolo[1,5-A]pyrazine compounds as allosteric modulators of mGluR5 receptors
Grant 8,703,946 - Conn , et al. April 22, 2
2014-04-22
Bicyclic Triazole And Pyrazole Lactams As Allosteric Modulators Of Mglur5 Receptors
App 20140057870 - Conn; P. Jeffrey ;   et al.
2014-02-27
Substituted Bicyclic Alkoxy Pyrazole Analogs As Allosteric Modulators Of Mglur5 Receptors
App 20130345203 - Conn; P. Jeffrey ;   et al.
2013-12-26
Substituted Bicyclic Alkoxy Pyrazole Analogs As Allosteric Modulators Of Mglur5 Receptors
App 20130345206 - Conn; P. Jeffrey ;   et al.
2013-12-26
Substituted Bicyclic Cycloalkyl Pyrazole Lactam Analogs As Allosteric Modulators Of Mglur5 Receptors
App 20130345204 - Conn; P. Jeffrey ;   et al.
2013-12-26
Substituted Bicyclic Aralkyl Pyrazole Lactam Analogs As Allosteric Modulators Of Mglur5 Receptors
App 20130345205 - Conn; P. Jeffrey ;   et al.
2013-12-26
Bicyclic triazole and pyrazole lactams as allosteric modulators of mGluR5 receptors
Grant 8,592,422 - Conn , et al. November 26, 2
2013-11-26
Bicyclic Oxazole And Thiazole Compounds And Their Use As Allosteric Modulators Of Mglur5 Receptors
App 20130261107 - Conn; P. Jeffrey ;   et al.
2013-10-03
Bicyclic Oxazole Lactams As Allosteric Modulators Of Mglur5 Receptors
App 20130252943 - Conn; P. Jeffrey ;   et al.
2013-09-26
Substituted Imidazopyrimidin-5(6h)-ones As Allosteric Modulators Of Mglur5 Receptors
App 20130245043 - Conn; P. Jeffrey ;   et al.
2013-09-19
Macrocyclic spiropiperidine beta-secretase inhibitors for the treatment of Alzheimer's disease
Grant 8,399,473 - Nantermet , et al. March 19, 2
2013-03-19
2,3,4,6-substituted pyridyl derivative compounds useful as beta-secretase inhibitors for the treatment of alzheimer's disease
Grant 8,394,837 - Nantermet , et al. March 12, 2
2013-03-12
Bicyclic spiropiperidine beta-secretase inhibitors for the treatment of Alzheimer's disease
Grant 8,377,954 - Stauffer , et al. February 19, 2
2013-02-19
Tertiary carbinamines having substituted heterocycles which are active as .beta.-secretase inhibitors for the treatment of alzheimer's disease
Grant 8,338,614 - McGaughey , et al. December 25, 2
2012-12-25
Bicyclic Pyrazole Compounds As Allosteric Modulators Of Mglur5 Receptors
App 20120295913 - Conn; P. Jeffrey ;   et al.
2012-11-22
Spiropiperidine beta-secretase inhibitors for the treatment of alzheimer's disease
Grant 8,293,759 - Stauffer , et al. October 23, 2
2012-10-23
Bicyclic Triazole And Pyrazole Lactams As Allosteric Modulators Of Mglur5 Receptors
App 20120225844 - Conn; P. Jeffrey ;   et al.
2012-09-06
Dihydronaphthyridinyl(organo)methanone Analogs As Positive Allosteric Mglur5 Modulators
App 20120178776 - Conn; P. Jeffrey ;   et al.
2012-07-12
Naphthyridinone Analogs As Mglur5 Positive Allosteric Modulators
App 20120172391 - Conn; P. Jeffrey ;   et al.
2012-07-05
Spiropiperidine beta-secretase inhibitors for the treatment of alzheimer's disease
Grant 8,211,904 - Coburn , et al. July 3, 2
2012-07-03
Piperidine and pyrrolidine beta-secretase inhibitors for the treatment of alzheimer's disease
Grant 8,143,405 - Stauffer March 27, 2
2012-03-27
P2X3 Receptor Antagonists for Treatment of Pain
App 20120064181 - Burgey; Christopher S. ;   et al.
2012-03-15
Spiropiperidine compounds useful as beta-secretase inhibitors for the treatment of alzheimer's disease
Grant 8,114,887 - Barrow , et al. February 14, 2
2012-02-14
Substituted 6-methylnicotinamides As Mglur5 Positive Allosteric Modulators
App 20110294858 - Conn; P. Jeffrey ;   et al.
2011-12-01
2,4,6-substituted pyridyl derivative compounds useful as beta-secretase inhibitors for the treatment of Alzheimer's Disease
Grant 7,968,571 - Barrow , et al. June 28, 2
2011-06-28
1,3,5-substituted phenyl derivative compounds useful as beta-secretase inhibitors for the treatment of Alzheimer's disease
Grant 7,847,100 - Barrow , et al. December 7, 2
2010-12-07
Spiropiperidine beta-secretase inhibitors for the treatment of Alzheimer's Disease
App 20100298342 - Egbertson; Melissa S. ;   et al.
2010-11-25
Aminomethyl beta-secretase inhibitors for the treatment of alzheimer's disease
Grant 7,820,674 - Coburn , et al. October 26, 2
2010-10-26
Bicyclic Spiropiperidine Beta-secretase Inhibitors For The Treatment Of Alzheimer's Disease
App 20100076004 - Stauffer; Shaun R. ;   et al.
2010-03-25
Spiropiperidine Beta-secretase Inhibitors For The Treatment Of Alzheimer's Disease
App 20100069419 - Stauffer; Shaun R. ;   et al.
2010-03-18
Piperidine and pyrrolidine beta-secretase inhibitors for the treatment of alzheimer's disease
App 20100041667 - Stauffer; Shaun R.
2010-02-18
Macrocyclic Spiropiperidine Beta-secretase Inhibitors For The Treatment Of Alzheimer's Disease
App 20100029701 - Nantermet; Philippe G. ;   et al.
2010-02-04
Phenylamide and pyridylamide beta-secretase inhibitors for the treatment of Alzheimer's disease
Grant 7,550,481 - Barrow , et al. June 23, 2
2009-06-23
Aminomethyl Beta-Secretase Inhibitors for the Treatment of Alzheimer's Disease
App 20080153846 - Coburn; Craig A. ;   et al.
2008-06-26
Tertiary Carbinamines Having Substituted Heterocycles Which Are Active As Beta-Secretase Inhibitors For The Treatment Of Alzheimer's Disease
App 20080139538 - McGaughey; Georgia B. ;   et al.
2008-06-12
Benzylether and benzylamino beta-secretase inhibitors for the treatment of Alzheimer's disease
Grant 7,354,942 - Nantermet , et al. April 8, 2
2008-04-08
2,4,6-Substituted Pyridyl Derivative Compounds Useful as Beta-Secretase Inhibitors for the Treatment of Alzheimer's Disease
App 20080015233 - Barrow; James C. ;   et al.
2008-01-17
2,3,4,6-Substituted Pyridyl Derivative Compounds Useful As Beta-Secretase Inhibitors For The Treatment Of Alzheimer's Disease
App 20070293497 - Nantermet; Philippe G. ;   et al.
2007-12-20
1,3,5-Substituted Phenyl Derivative Compounds Useful as Beta-Secretase Inhibitors for the Treatment of Alzheimer's Disease
App 20070244119 - Barrow; James C. ;   et al.
2007-10-18
Spiropiperidine compounds useful as beta-secretase inhibitors for the treatment of alzheimer' s disease
App 20070197571 - Barrow; James C. ;   et al.
2007-08-23
Phenylamide and pyridylamide beta-secretase inhibitors for the treatment of alzheimer's disease
App 20070142634 - Barrow; James C. ;   et al.
2007-06-21
Benzylether and benzylamino beta-secretase inhibitors for the treatment of alzheimer's disease
App 20070088165 - Nantermet; Philippe G. ;   et al.
2007-04-19
Spiropiperidine beta-secretase inhibitors for the treatment of Alzheimer's disease
App 20070021454 - Coburn; Craig A. ;   et al.
2007-01-25

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed